Used as an intermediate in the synthesis of pharmaceutical compounds, particularly in the development of kinase inhibitors for cancer treatment. Its structure supports selective binding to enzyme active sites, making it valuable in creating targeted therapies. Commonly employed in research settings for structure-activity relationship (SAR) studies due to its chiral center and functional groups that allow further modification. Also utilized in the preparation of peptidomimetic compounds aimed at improving metabolic stability and bioavailability in drug candidates.